PharmChem, Inc. Announces Shareholder Approval of Acquisition by Alcohol Monitoring Systems, Inc.
PharmChem (OTC: PCHM) announced that shareholders have approved its acquisition by Alcohol Monitoring Systems, Inc. at a special meeting held on August 27, 2025. According to the agreement terms, PharmChem shareholders will receive $3.75 per share in cash consideration.
The transaction is expected to be finalized at the close of business on August 28, 2025. The company has provided contact information for shareholders with specific questions regarding the acquisition.
PharmChem (OTC: PCHM) ha comunicato che gli azionisti hanno approvato la sua acquisizione da parte di Alcohol Monitoring Systems, Inc. durante una riunione straordinaria tenuta il 27 agosto 2025. In base ai termini dell'accordo, agli azionisti di PharmChem saranno corrisposti 3,75 $ per azione in contanti.
L'operazione dovrebbe concludersi alla chiusura delle contrattazioni del 28 agosto 2025. La società ha fornito informazioni di contatto per gli azionisti che avessero domande specifiche sull'acquisizione.
PharmChem (OTC: PCHM) anunció que los accionistas aprobaron su adquisición por parte de Alcohol Monitoring Systems, Inc. en una junta extraordinaria celebrada el 27 de agosto de 2025. Según los términos del acuerdo, los accionistas de PharmChem recibirán 3,75 $ por acción en efectivo.
Se espera que la transacción se finalize al cierre de la jornada del 28 de agosto de 2025. La compañía ha facilitado información de contacto para los accionistas con preguntas específicas sobre la adquisición.
PharmChem (OTC: PCHM)은 2025년 8월 27일 열린 임시 주주총회에서 Alcohol Monitoring Systems, Inc.에 의한 인수를 주주들이 승인했다고 발표했습니다. 계약 조건에 따라 PharmChem 주주들은 주당 3.75달러를 현금으로 받게 됩니다.
이 거래는 2025년 8월 28일 장 마감 시 최종 완료될 것으로 예상됩니다. 회사는 인수에 관해 구체적인 문의가 있는 주주들을 위한 연락처 정보를 제공했습니다.
PharmChem (OTC: PCHM) a annoncé que ses actionnaires ont approuvé son acquisition par Alcohol Monitoring Systems, Inc. lors d'une assemblée extraordinaire tenue le 27 août 2025. Conformément aux termes de l'accord, les actionnaires de PharmChem recevront 3,75 $ par action en espèces.
La transaction devrait être finalisée à la clôture des marchés le 28 août 2025. La société a fourni des coordonnées pour les actionnaires ayant des questions spécifiques concernant l'acquisition.
PharmChem (OTC: PCHM) gab bekannt, dass die Aktionäre bei einer außerordentlichen Hauptversammlung am 27. August 2025 dem Erwerb durch Alcohol Monitoring Systems, Inc. zugestimmt haben. Laut den Vereinbarungen erhalten PharmChem-Aktionäre 3,75 $ pro Aktie in bar.
Die Transaktion soll zum Handelsschluss am 28. August 2025 abgeschlossen werden. Das Unternehmen hat Kontaktinformationen für Aktionäre bereitgestellt, die spezifische Fragen zur Übernahme haben.
- Cash consideration of $3.75 per share for shareholders
- Quick closing timeline with clear execution date
- Company will be delisted from OTC markets following acquisition
The Company expects the consummation of the transaction to be effective at the close of business on Thursday, August 28, 2025.
If shareholders have further, specific questions, please email our CFO Shana Veale at sveale@pharmchem.com and we will set up a call.
Tim Eriksen
Chairman of the Board
About PharmChem, Inc.
PharmChem, Inc. ("PharmChem") (OTC: PCHM), headquartered in
Safe Harbor for Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and Section 27A of the Securities Act of 1933 ("Forward-looking Statements"), which are subject to the "safe harbor" created by these Sections. Forward-looking statements are statements about future financial results, future products or services and www.pharmchem.com other events that have not yet occurred. These forward-looking statements contain words such as, but not limited to, "expect", "anticipate", "estimate", "believe", "will", "may" or "might". Investors should be aware that actual results may differ materially from our expressed expectations because of risks and uncertainties about the future. We will not necessarily update the information in this letter if any forward-looking statement later turns out to be inaccurate.
View original content to download multimedia:https://www.prnewswire.com/news-releases/pharmchem-inc-announces-shareholder-approval-of-acquisition-by-alcohol-monitoring-systems-inc-302540192.html
SOURCE PharmChem, Inc.
FAQ
What is the acquisition price per share for PharmChem (PCHM) shareholders?
When will the PharmChem (PCHM) acquisition by Alcohol Monitoring Systems close?
Who is acquiring PharmChem (PCHM)?
How can PharmChem shareholders get more information about the acquisition?
